Published in:
Open Access 01-12-2019 | Obesity | Research
TREM2 regulates obesity-induced insulin resistance via adipose tissue remodeling in mice of high-fat feeding
Published in: Journal of Translational Medicine | Issue 1/2019
Login to get accessAbstract
Background
Adipose tissue remodeling plays a significant role in obesity-induced insulin resistance. Published studies reported that level of trigger receptor expressed on myeloid cells 2 (TREM2) in adipose tissue is up-regulated in animal models of obesity. This study aims to investigate whether TREM2 regulates obesity-induced insulin resistance via modulating adipose tissue remodeling in mice of high-fat diet (HFD).
Methods
Wild-type (WT) and TREM2−/− mice were both fed with a controlled-fat diet (CFD) or HFD for 12 weeks and studied for obesity and insulin resistance. Meanwhile, epididymal adipose tissue (EAT) was examined for morphological and pathological changes to determine adipose tissue remodeling. After that, adipocyte-derived MCP-1 was measured in adipocytes, adipose tissue and circulation. Next, inflammatory cytokines were determined in adipose tissue macrophages (ATM). At last, livers were analyzed for hepatic steatosis.
Results
TREM2−/− mice on HFD had increased obesity and insulin resistance compared with WT counterparts. Adipose tissue from TREM2−/− mice exhibited reduced mass but greater adipocyte hypertrophy and increased adipocyte death. Besides, adipocyte-derived MCP-1 was down-regulated in TREM2−/− mice, and circulating MCP-1 level was lower than that of WT mice. Furthermore, TREM2−/− mice displayed reduced infiltration of F4/80+CD11c+ macrophages into adipose tissue, which was unable to form crown-like structures (CLS) to clean dead adipocytes and cellular contents. Also, TREM2 deficiency augmented inflammatory response of adipose tissue macrophages in HFD mice. In addition, TREM2−/− mice demonstrated more severe hepatic steatosis than WT counterparts under HFD feeding.
Conclusions
Trigger receptor expressed on myeloid cells 2 may function as a feedback mechanism to curb obesity-induced insulin resistance via regulating adipose tissue remodeling.